Insider buying last 90 days
No open-market insider purchases were filed for NOVT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Novanta reported third quarter 2026 financial results on 9 November, following a preview that flagged analysts expecting 21.5% year-on-year revenue growth after a prior quarter in which both EBITDA and revenue guidance topped forecasts. Ahead of the print, a liquidity mapping analysis from Stock Traders Daily described strong sentiment across all horizons and an overweight bias on the stock. At the last reported quarter, 5 August, Novanta posted adjusted EPS of $0.89 against a $0.83 estimate, with a 2.4% reaction, part of a stretch of 5 beats in the last 8 quarters.
Shares closed at $145.98, up 8% on the day, sitting between the 50-day average of $142.25 and the 200-day average of $142.48. One-year return stands at 36.1%, though the three-month return is -13%. The GekkoIndex reads 57.6, placing the stock in the Neutral zone, up 2.4 over five days. Price sits 6.4% above Gekko Fair Value of $137.21.
No confirmed next earnings date appears on the calendar. Smart-money data shows no insider, Congress or unusual options activity in their respective 90-day and 30-day windows, and there are 0 trailblazer holders. Seasonally, the next 20 trading days have averaged +5.6% over 5 years, rising in 3 of them. The sole covering analyst holds a buy rating with a consensus target of $194.50, implying 33.2% upside from current levels.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Novanta scores 4 supportive, 0 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed1 headwind
Below 50 and 200-day
Close $118.88 is below the 50-day ($140.29) and 200-day ($142.12) averages, and the 50-day is below the 200-day.
See the chart68.9, Accumulation
Reading 68.9 is in the Accumulation zone.
See the GekkoIndex8.5% below
Price is 8.5% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 99 days
Next report Feb 22, 2027, 99 days away — outside a typical 20-trading-day hold.
See earnings+6.4% on average
From this point in the calendar, the next 20 trading days averaged +6.4% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Novanta closed at $118.88 on Nov 13, 2026, +7.7% over the past year, inside a 52-week range of $98.27 to $176.38.
Use the left and right arrow keys to read daily values.
Put NOVT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Novanta designs and manufactures engineered components used inside larger equipment made by other manufacturers, with a focus on photonics, vision, and precision motion technology. Its parts and sub-assemblies serve original equipment manufacturers in the medical and industrial fields, and the company is recognized for building the specialized building blocks that go into imaging, laser, and motion-control equipment rather than selling finished products directly to end users.
The business is arranged into three segments. The photonics group makes laser-based systems, including scanning and beam-steering tools and several laser types, used in manufacturing, measurement, medical imaging, and applications like DNA sequencing. The vision group supplies medical instruments such as insufflators and pumps, visualization and wireless communication tools for operating rooms, plus machine vision, RFID, and spectrometry equipment. The precision motion group provides encoders, motors, servo drives, motion control systems, robotic end-effectors, and air bearings. Novanta reaches customers through a direct sales force along with resellers, distributors, and system integrators, and sells under a number of established brand names.
The company began in 1968 and previously operated as GSI Group before adopting the Novanta name in May 2016. It is headquartered in Bedford, Massachusetts, and its shares are listed on the NASDAQ under the ticker NOVT.
Novanta’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 68.9, in the Accumulation zone, up 6.4 points over five sessions.
Up 6.4 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 27 | +3.2% | +7.7% | ||
| Accumulation (current zone) | 272 | +0.2% | +0.4% | ||
| Neutral | 385 | −0.3% | −0.5% | ||
| Distribution | 17 | +0.2% | −4.1% | ||
| Selling | 1 | Too few readings yet | |||
Average NOVT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Novanta trades 8.5% below Gekko Fair Value of $129.89, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Novanta shares are worth, recalculated every trading day.
$129.89
Gekko Fair Value, Nov 14, 2026
8.5% Undervalued
At the end of Aug 2026 the price was 16.5% above the estimate.
No open-market insider purchases were filed for Novanta, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for NOVT in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in NOVT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Novanta has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold NOVT.
Novanta reports on Feb 22, 2027 (99 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 22, 2027
99 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 9, 2026 | $1.05 est $0.97 | $305.0M est $301.0M | −8.5% |
| Aug 5, 2026 | $0.89 est $0.83 | $265.8M est $262.3M | +2.4% |
| May 11, 2026 | $0.51 est $0.83 | $257.7M est $253.4M | +15.1% |
| Feb 23, 2026 | $0.91 est $0.91 | $258.3M est $255.6M | −5.8% |
| Nov 3, 2025 | $0.87 est $0.84 | $247.8M est $255.6M | +1.8% |
| Aug 5, 2025 | $0.76 est $0.74 | $241.0M est $248.5M | −8.3% |
| May 6, 2025 | $0.59 est $0.67 | $233.4M est $240.7M | −0.9% |
| Feb 25, 2025 | $0.76 est $0.71 | $238.1M est $244.6M | +8.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Novanta is $185.00, +55.6% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 12 | Robert W. Baird | $175 | +47.2% |
| Oct 5 | William Blair | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Novanta averaged +6.4% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.5% | 3 of 5 |
| Next 10 trading days | +1.2% | 2 of 5 |
| Next 15 trading days | +3.9% | 3 of 5 |
| Next 20 trading days | +6.4% | 3 of 5 |
| Next 30 trading days | +5.7% | 3 of 5 |
For scale, NOVT’s typical 20-trading-day move in either direction is about 6.4%.
Novanta’s market cap is $4.50B, with a P/E ratio of 87.9 and revenue of $1.09B over the last twelve months.
Coverage of Novanta this week reads positive: 2 positive, 2 neutral and 0 negative headlines.
Novanta’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| EMREmerson Electric | Neutral | 16.5% above |
| KEYSKeysight Technologies | Accumulation | 3.4% below |
| QQnity Electronics | Neutral | 4.7% below |
| FTVFortive | Neutral | 15.1% above |
| NXTNextpower | Neutral | 3.0% below |
| NVMINova | Neutral | 4.2% above |
A peer links to its own page where one exists.
Novanta’s market cap is $4.50B at the Nov 13, 2026 close of $118.88, with 37.82M shares outstanding. The shares trade on a P/E ratio of 87.9.
The consensus analyst 12-month price target for Novanta is $185.00, +55.6% from the last close. Of the 2 firms that rated the stock in the last 90 days, 2 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Novanta is undervalued: the Nov 13, 2026 close of $118.88 is 8.5% below Gekko Fair Value of $129.89. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Novanta is expected to report on Feb 22, 2027 (99 days away). Analysts expect earnings of $0.96 per share on revenue of $309.7M. Novanta beat the earnings estimate in 6 of its last 8 reports, moving 6.4% on average across the report.
Novanta’s 52-week high is $176.38 and its 52-week low is $98.27; it closed at $118.88 on Nov 13, 2026, +7.7% over the past year. Over the last five years the shares peaked at $187.61 on Jun 30, 2023.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.